>

MEETINGS / EVENTS

RSS

May 05 - 07 2014, 12:00 AM - 12:00 AM

2014 ASA Legislative Conference

>

FDA MEDWATCH ALERTS

April 18, 2014

Propofol Injectable Emulsion, USP by Hospira: Recall - Visible Particulates

Summary:

Propofol Injectable Emulsion USP by Hospira Recall Visible Particulates

April 18, 2014

FDA MedWatch - ARKON Anesthesia Delivery System with Version 2.0 Software by Spacelabs Healthcare: Class I Recall

Summary:

FDA MedWatch Class I Recall 4 18 14

March 28, 2014

FDA Update on the Shortage of Normal Saline

Summary:

FDA Update on the Shortage of Normal Saline

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-14CE

... Read more »

Single Copies, Member Price: $360

ASA Responds to Latest Request in SGR Reform Discussion

Friday, July 12, 2013

On July 11, ASA responded to the most recent request for feedback from the U.S. House Committee on Energy and Commerce regarding their proposal to repeal and replace the Medicare Sustainable Growth Rate (SGR) formula. This letter represents the ASA's fourth set of formal comments submitted to the Committee. 

ASA highlighted concerns that the "current draft leaves unresolved key issues for anesthesiologists,” including how some of most important components of the payment reform will be set.

ASA remains committed to repealing and replacing the flawed SGR formula with a system that more accurately reflects the cost of providing care to Medicare patients.

Review the July 11 response.

Review an ASA section-by-section summary of the Committee's SGR proposal.

Review ASA's previous responses:
June
April
February

« Back to Washington Alerts